About the PREVAIL Network

The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.
Thumb_Brochure_PREVAIL_725h

Related Resources

Brochure

Vaccine Development

Video

Global Vaccine Development

Brochure

Full-Service Global Support for COVID-19 Studies

Brochure

About FHI Clinical

Brochure

Our Experience in sub-Saharan Africa

Indication Overview

Our Clinical Trial Experience With Malaria

Video

Participant Recruitment and Retention Can Require Agile Solutions

Indication Overview

Our Clinical Trial Experience With Oncology